Please provide your email address to receive an email when new articles are posted on . Nearly half of people diagnosed with advanced cancer between 2018 and 2022 did not undergo next-generation ...
When comprehensive tissue next-generation sequencing (NGS) fails, liquid biopsy should be the reflex strategy, especially in ...
A Bangalore woman's advanced ovarian cancer treatment transformed after genetic testing revealed a DNA repair deficiency, not ...
Kelly, MD, MBA, and participants discussed key considerations for biomarker testing in upper GI cancers. Biomarker status has ...
In an era where targeted therapies and immunotherapy are reshaping first-line treatment, the stakes of getting the workup right—and getting it right the first time—have never been higher. This ...
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer Among 556 patients with mNSCLC, 98.8% received ...
According to MarketsandMarkets™, the Molecular Infectious Disease Testing Market is projected to grow from about USD 11.30 ...
The Global Preimplantation Genetic Testing Market presents key opportunities driven by rising awareness of genetic disease prevention, advanced genetic testing technologies, and increased infertility ...
LabGenomics, a national diagnostics company specializing in advanced anatomical pathology and molecular testing, today ...
Q1 2026 Earnings Call April 28, 2026 4:30 PM EDTCompany ParticipantsPriya Vedaraman - Senior Vice President of FinanceAnthony Zook ...
On April 14, 2026, the United States Food and Drug Administration (“FDA”) issued a draft guidance for sponsors seeking approval of human ...
New innovations improve microbial identification, outbreak tracking, and NGS workflows, enhancing diagnostic speed, accuracy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results